Ready to save your company time and money?
All while working with the most complete and accurate data on the market.
Historical trials’ performance- Standard of Care and drug reimbursement
- Patient journeys powered by RWD
- A single platform for all of your teams
- API to effortlessly pull data into your internal tools
“Establishing reimbursement for a single drug across multiple countries used to take us two days of research. Now it takes us under an hour.”
Thomas Christie
Director, Business Insights, Syneos Health
“The changing reimbursement landscape demands ongoing monitoring, which is resource-intensive and costly. With TrialHub, we can check reimbursement status in minutes rather than hours.”
Donna Hanson
VP Strategy and Optimization, Advanced Clinical
“When we are pulling together a strategy, we like to be able to compare the asset we’ll be investigating to the SoC in that country. It gives us a better idea how investigators will receive the protocol.”
Stacy Weil
Senior Vice President, Patient Centricity and Business Operations, Premier Research
“Standard of care speaks to the eligibility of a patient. If a SoC drug renders a patient ineligible to participate in the study, that’s going to impact our recruitment and timelines.”
Annie Rotten
Manager, Strategic Site Solutions, Avance Clinical
“We’ve been able to partner with our clients—small biotech and pharma—and give them realistic enrollment projections.”
Curtis Head
Co-founder and CEO, PRC Clinical
“The platform makes it easy to go back after starting the trial and determine if things are still the same or if we need to re-think our strategy because some key factor is now in play.”
Stacy Weil
Senior Vice President, Patient Centricity and Business Operations, Premier Research
“Even in the middle of the meeting, we can get on TrialHub and check in real time.”
Irma Usinskiene
Head of Clinical Operations, Biomapas
“TrialHub helps us find out if a study will be successful and provides robust data to back it up.”
Stacy Collins
Director, Study Start-up and Feasibility, Bionical Emas
“When we are pulling together a strategy, we like to be able to compare the asset we’ll be investigating to the SoC in that country. It gives us a better idea how investigators will receive the protocol.”
Stacy Weil
Senior Vice President, Patient Centricity and Business Operations, Premier Research
“There’s a lot of data out there and not all of it is accurate. Data gets stale. Being able to see what’s actually happening for trials and sponsors saves us time and money.”
Curtis Head
Co-founder and CEO, PRC Clinical